Diagnostics News and Research

RSS

Experimental therapy delays viral rebound in SHIV-infected macaques

A recent preclinical study by U.S. Military HIV Research Program (MHRP) researchers showed that an experimental therapy combining a TLR7 agonist and two broadly neutralizing antibodies delayed viral rebound in SHIV-infected macaques after antiretroviral therapy (ART) interruption.

2 Mar 2021

Study reveals the effect of digital devices on children's cognitive, socio-emotional development

What can you see in this picture (next to the article)? Say what comes to your mind immediately! If you said „star", you focus rather on the details, if you said „sun", then rather on the global pattern.

2 Mar 2021

Researchers confirm a threshold value for non-invasive imaging biomarker

Breast cancer is the commonest fatal cancer in women. Early detection increases a woman's chances of recovery. Magnetic Resonance Imaging (MRI) is an accurate technique for detecting and classifying tumors in breast tissue.

2 Mar 2021

Scientists test the effect of natural product isolated from sea sponge on cancer cells

Scientists from Far Eastern Federal University together with Russian and German colleagues, continue studying antitumor compounds synthesized based on bioactive molecules isolated from a sea sponge.

1 Mar 2021

Researchers develop mutant gene-targeted immunotherapy approach to fight cancers

A novel targeted immunotherapy approach developed by researchers at the Ludwig Center, the Lustgarten Laboratory, and Bloomberg~Kimmel Institute for Cancer Immunotherapy at the Johns Hopkins Kimmel Cancer Center employs new antibodies against genetically altered proteins to target cancers.

1 Mar 2021

FDA grants emergency use authorization for QuickVue At-Home COVID-19 Test

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the Quidel QuickVue At-Home COVID-19 Test, another antigen test where certain individuals can rapidly collect and test their sample at home, without needing to send a sample to a laboratory for analysis.

1 Mar 2021

Nanobowls show potential for diagnostics and treatment of Alzheimer's

Scientists are still a long way from being able to treat Alzheimer's Disease, in part because the protein aggregates that can become brain plaques, a hallmark of the disease, are hard to study.

26 Feb 2021

Programmed magnetic nanobeads rapidly diagnose COVID-19

COVID-19 can be diagnosed in 55 minutes or less with the help of programmed magnetic nanobeads and a diagnostic tool that plugs into an off-the-shelf cell phone, according to Rice University engineers.

26 Feb 2021

Antibody and T cell response to SARS-CoV-2 persist up to 8 months: Study of Ski Resort Ischgl

The first instance of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak in Austria was observed in the Ski resort Ischgl in early March 2020. Later, the virus spread across Austria and other countries in Northern Europe.

25 Feb 2021

Renalytix AI and University of Utah announce partnership to improve kidney health

Renalytix AI plc, an artificial intelligence-enabled in vitro diagnostics company, and the University of Utah, one of the top research institutions in the United States, today announced a partnership to improve kidney health and reduce the risk of kidney failure for large scale populations in the earliest stages of kidney disease.

25 Feb 2021

UC San Diego receives $33 million from NIH for five COVID-19 diagnostic projects

University of California San Diego was awarded five Rapid Acceleration of Diagnostics (RADx) projects by the National Institutes of Health, totaling nearly $33 million over four years.

25 Feb 2021

COVID-19 Antigen Self-Test from Siemens Healthineers receives special approval in Germany for self-use by laypeople

Siemens Healthineers announced today that the CLINITEST Rapid COVID-19 Antigen Self-Test has received limited special approval from the Federal Office for Drugs and Medical Devices.

From Siemens Healthineers 25 Feb 2021

Novel single-particle digital assay using plasmonic nanobubbles

An interdisciplinary team from the University of Texas applied DIAMOND to the respiratory syncytial virus (RSV) diagnostics and demonstrated that DIAMOND is 150 times more sensitive than commercial lateral flow assays. They found that the measurements are completed within 2 minutes. The results of this study are published on the medRxiv* preprint server.

25 Feb 2021

Diagnostics News and Research

Experimental therapy delays viral rebound in SHIV-infected macaques

Study reveals the effect of digital devices on children's cognitive, socio-emotional development

Researchers confirm a threshold value for non-invasive imaging biomarker

Scientists test the effect of natural product isolated from sea sponge on cancer cells

Researchers develop mutant gene-targeted immunotherapy approach to fight cancers

FDA grants emergency use authorization for QuickVue At-Home COVID-19 Test

Nanobowls show potential for diagnostics and treatment of Alzheimer's

Programmed magnetic nanobeads rapidly diagnose COVID-19

Antibody and T cell response to SARS-CoV-2 persist up to 8 months: Study of Ski Resort Ischgl

Renalytix AI and University of Utah announce partnership to improve kidney health

UC San Diego receives $33 million from NIH for five COVID-19 diagnostic projects

COVID-19 Antigen Self-Test from Siemens Healthineers receives special approval in Germany for self-use by laypeople

Novel single-particle digital assay using plasmonic nanobubbles

High-throughput genetic analysis can help dissect the mechanism of disease inheritance

In Vivo Probes for Detecting Inflammation Markers in Humans and Animals

A practical guide to critical parameters in acute care testing

Microfluidic chip and AI-powered automated microscope help measure hemoglobin levels

AMP survey results indicate significant decline in molecular diagnostic testing

TBE patients continue to be affected by long-term problems

New rapid diagnostic tests can differentiate between COVID-19 variants and multiple viruses

Event guide: 16th Clinical Biomarkers & CDx Summit Europe eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News